(Total Views: 683)
Posted On: 08/02/2020 3:08:11 PM
Post# of 153990
Re: Rubraquercus #46666
Rubraquercus,
I believe you are referring the New Scoring System for CCR5 Immunohistochemistry in Cancer.
https://incelldx.com/incelldx-content/uploads...rt-003.pdf
This quantifies CCR5 immuno-histochemistry that creates H-Scores to quantify on a tumor-by-tumor basis what the individuals “score” is.
Basically can create a base-line, so when a patient is treated with Leronlimab, it would be possible to ascertain before hand the possible response.
This will be useful for treatments, follow up and, of course for trials in Oncology as different cancers are expressed differently as far as receptors of CCR5 is concerned.
I believe you are referring the New Scoring System for CCR5 Immunohistochemistry in Cancer.
https://incelldx.com/incelldx-content/uploads...rt-003.pdf
This quantifies CCR5 immuno-histochemistry that creates H-Scores to quantify on a tumor-by-tumor basis what the individuals “score” is.
Basically can create a base-line, so when a patient is treated with Leronlimab, it would be possible to ascertain before hand the possible response.
This will be useful for treatments, follow up and, of course for trials in Oncology as different cancers are expressed differently as far as receptors of CCR5 is concerned.
(3)
(0)
